FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses
February 9, 2020 Returned Product a Hidden Challenge for Cannabis Companies Soon after cannabis products started flying off shelves following legalization, Canopy Growth Corp. had a $26.9 million problem.
